Literature DB >> 11768921

Is acetylsalicylic acid plus dipyridamole superior to ASA alone for secondary prevention of stroke?

B Dalton1, C Papoushek, M F Evans.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11768921      PMCID： PMC2018453     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  15 in total

Review 1.  Antithrombotic and thrombolytic therapy for ischemic stroke.

Authors:  G W Albers; P Amarenco; J D Easton; R L Sacco; P Teal
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

2.  Low-dose aspirin and stroke. "It ain't necessarily so".

Authors:  M L Dyken; H J Barnett; J D Easton; W S Fields; V Fuster; V Hachinski; J W Norris; D G Sherman
Journal:  Stroke       Date:  1992-10       Impact factor: 7.914

Review 3.  Aspirin dose in stroke prevention: beautiful hypotheses slain by ugly facts.

Authors:  H J Barnett; M Kaste; H Meldrum; M Eliasziw
Journal:  Stroke       Date:  1996-04       Impact factor: 7.914

Review 4.  Extended-release dipyridamole/aspirin.

Authors:  P S Hervey; K L Goa
Journal:  Drugs       Date:  1999-09       Impact factor: 9.546

5.  The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results.

Authors:  B Farrell; J Godwin; S Richards; C Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-12       Impact factor: 10.154

Review 6.  Pharmacokinetic optimisation of the treatment of embolic disorders.

Authors:  D M Lutomski; M Bottorff; K Sangha
Journal:  Clin Pharmacokinet       Date:  1995-01       Impact factor: 6.447

7.  "AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia.

Authors:  M G Bousser; E Eschwege; M Haguenau; J M Lefaucconnier; N Thibult; D Touboul; P J Touboul
Journal:  Stroke       Date:  1983 Jan-Feb       Impact factor: 7.914

Review 8.  Aspirin in ischemic cerebrovascular disease. How strong is the case for a different dosing regimen?

Authors:  C Patrono; G J Roth
Journal:  Stroke       Date:  1996-04       Impact factor: 7.914

Review 9.  Aspirin wars: the optimal dose of aspirin prevent stroke.

Authors:  R G Hart; M J Harrison
Journal:  Stroke       Date:  1996-04       Impact factor: 7.914

10.  Risks of gastrointestinal bleeding during secondary prevention of vascular events with aspirin--analysis of gastrointestinal bleeding during the UK-TIA trial.

Authors:  J Slattery; C P Warlow; C J Shorrock; M J Langman
Journal:  Gut       Date:  1995-10       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.